Back to All Events

Navigating a Path to Advance the Use of Liquid Biopsies for Early Cancer Screening and Detection (Panel Discussion)

  • Festival of Genomics and Biodata Boston, MA (map)

In this event at the Festival of Genomics and Biodata, BLOODPAC members will discuss current progress and clinical advances in liquid biopsy for early cancer detection, and current challenges and opportunities in multi-cancer early detection testing and MRD testing/patient monitoring. Panelists include Jonathan Beer (Senior Director of Diagnostic Sciences, Bristol Meyers Squibb), Lauren Leiman (Executive Director, BLOODPAC), and Carl Barrett (VP Translational Sciences--Oncology, AztraZeneca).

Source: https://festivalofgenomics-boston.com/boston/en/page/day-1
Previous
September 22

Moving Towards Global Harmonization of Liquid Biopsy Frameworks and Standards: The BLOODPAC Experience (Talk)
Next
November 8

Panel Discussion: Creating Consensus on Lexicons, Standards & Frameworks for MCED and MRD Tests for Community Benefit